[Individualized treatment recommendations for lung cancer patients at different stages of treatment during the outbreak of 2019 novel coronavirus disease epidemic].
Identifieur interne : 000039 ( PubMed/Checkpoint ); précédent : 000038; suivant : 000040[Individualized treatment recommendations for lung cancer patients at different stages of treatment during the outbreak of 2019 novel coronavirus disease epidemic].
Auteurs : Z. Zhao [République populaire de Chine] ; H. Bai ; J C Duan ; J. WangSource :
- Zhonghua zhong liu za zhi [Chinese journal of oncology] [ 0253-3766 ] ; 2020.
Abstract
In order to achieve the overall victory of the 2019 novel coronavirus disease epidemic in this 'war', especially to prevent the disease recurrence from rebounding during the resumption of labor, the government has not loosened any control of personnel mobility, which has obviously affected the normal examination and treatment of lung cancer patients under the influence of this epidemic. During the epidemic period, cancer patients with low immunity levels face the double ordeals of disease and epidemic situation. Compared with the general population, they are more likely to be infected with the new coronavirus. Among the infected cancer patients, lung cancer is the most common type. It is necessary to provide more appropriate individualized treatment recommendations for patients with lung cancer based on the epidemic situation of the patient's location and in combination with the patient's own condition. Through active prevention of infection, timely conversion of treatment strategies, online and offline joint control, and positive psychological counseling, we significantly hope to help patients with lung cancer to survive this difficult period.
DOI: 10.3760/cma.j.cn112152-20200228-00146
PubMed: 32125130
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:32125130Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Individualized treatment recommendations for lung cancer patients at different stages of treatment during the outbreak of 2019 novel coronavirus disease epidemic].</title><author><name sortKey="Zhao, Z" sort="Zhao, Z" uniqKey="Zhao Z" first="Z" last="Zhao">Z. Zhao</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Bai, H" sort="Bai, H" uniqKey="Bai H" first="H" last="Bai">H. Bai</name></author><author><name sortKey="Duan, J C" sort="Duan, J C" uniqKey="Duan J" first="J C" last="Duan">J C Duan</name></author><author><name sortKey="Wang, J" sort="Wang, J" uniqKey="Wang J" first="J" last="Wang">J. Wang</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32125130</idno><idno type="pmid">32125130</idno><idno type="doi">10.3760/cma.j.cn112152-20200228-00146</idno><idno type="wicri:Area/PubMed/Corpus">000325</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000325</idno><idno type="wicri:Area/PubMed/Curation">000325</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000325</idno><idno type="wicri:Area/PubMed/Checkpoint">000039</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000039</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Individualized treatment recommendations for lung cancer patients at different stages of treatment during the outbreak of 2019 novel coronavirus disease epidemic].</title><author><name sortKey="Zhao, Z" sort="Zhao, Z" uniqKey="Zhao Z" first="Z" last="Zhao">Z. Zhao</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Bai, H" sort="Bai, H" uniqKey="Bai H" first="H" last="Bai">H. Bai</name></author><author><name sortKey="Duan, J C" sort="Duan, J C" uniqKey="Duan J" first="J C" last="Duan">J C Duan</name></author><author><name sortKey="Wang, J" sort="Wang, J" uniqKey="Wang J" first="J" last="Wang">J. Wang</name></author></analytic><series><title level="j">Zhonghua zhong liu za zhi [Chinese journal of oncology]</title><idno type="ISSN">0253-3766</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In order to achieve the overall victory of the 2019 novel coronavirus disease epidemic in this 'war', especially to prevent the disease recurrence from rebounding during the resumption of labor, the government has not loosened any control of personnel mobility, which has obviously affected the normal examination and treatment of lung cancer patients under the influence of this epidemic. During the epidemic period, cancer patients with low immunity levels face the double ordeals of disease and epidemic situation. Compared with the general population, they are more likely to be infected with the new coronavirus. Among the infected cancer patients, lung cancer is the most common type. It is necessary to provide more appropriate individualized treatment recommendations for patients with lung cancer based on the epidemic situation of the patient's location and in combination with the patient's own condition. Through active prevention of infection, timely conversion of treatment strategies, online and offline joint control, and positive psychological counseling, we significantly hope to help patients with lung cancer to survive this difficult period.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32125130</PMID><DateRevised><Year>2020</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0253-3766</ISSN><JournalIssue CitedMedium="Print"><Volume>42</Volume><Issue>0</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>03</Day></PubDate></JournalIssue><Title>Zhonghua zhong liu za zhi [Chinese journal of oncology]</Title><ISOAbbreviation>Zhonghua Zhong Liu Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Individualized treatment recommendations for lung cancer patients at different stages of treatment during the outbreak of 2019 novel coronavirus disease epidemic].</ArticleTitle><Pagination><MedlinePgn>E007</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn112152-20200228-00146</ELocationID><Abstract><AbstractText>In order to achieve the overall victory of the 2019 novel coronavirus disease epidemic in this 'war', especially to prevent the disease recurrence from rebounding during the resumption of labor, the government has not loosened any control of personnel mobility, which has obviously affected the normal examination and treatment of lung cancer patients under the influence of this epidemic. During the epidemic period, cancer patients with low immunity levels face the double ordeals of disease and epidemic situation. Compared with the general population, they are more likely to be infected with the new coronavirus. Among the infected cancer patients, lung cancer is the most common type. It is necessary to provide more appropriate individualized treatment recommendations for patients with lung cancer based on the epidemic situation of the patient's location and in combination with the patient's own condition. Through active prevention of infection, timely conversion of treatment strategies, online and offline joint control, and positive psychological counseling, we significantly hope to help patients with lung cancer to survive this difficult period.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Z</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Zhong Liu Za Zhi</MedlineTA><NlmUniqueID>7910681</NlmUniqueID><ISSNLinking>0253-3766</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="Publisher" Language="chi"><AbstractText>为取得新型冠状病毒肺炎（COVID-19）战"疫"的全面胜利，特别是防止复工复产阶段的疫情反弹，社会各界对人员流动的管控仍无丝毫放松，肺癌患者的正常诊治在COVID-19疫情的影响下受到了巨大考验。在疫情期间，免疫力水平低下的恶性肿瘤患者面临着疾病与疫情的双重考验，相比普通人群，其更容易感染2019新型冠状病毒；在被感染的恶性肿瘤患者中，肺癌是最常见的类型。疫情期间需根据患者所在地的疫情现状，结合患者的自身情况，为肺癌患者提供更合适的个体化治疗建议，通过积极预防感染、及时的治疗策略转换、线上线下联合管控、积极的心理疏导等措施最大程度地帮助肺癌患者顺利度过这段艰难的时期。.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Individualized treatment</Keyword><Keyword MajorTopicYN="N">Lung neoplasms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32125130</ArticleId><ArticleId IdType="doi">10.3760/cma.j.cn112152-20200228-00146</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>République populaire de Chine</li></country><settlement><li>Pékin</li></settlement></list><tree><noCountry><name sortKey="Bai, H" sort="Bai, H" uniqKey="Bai H" first="H" last="Bai">H. Bai</name><name sortKey="Duan, J C" sort="Duan, J C" uniqKey="Duan J" first="J C" last="Duan">J C Duan</name><name sortKey="Wang, J" sort="Wang, J" uniqKey="Wang J" first="J" last="Wang">J. Wang</name></noCountry><country name="République populaire de Chine"><noRegion><name sortKey="Zhao, Z" sort="Zhao, Z" uniqKey="Zhao Z" first="Z" last="Zhao">Z. Zhao</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000039 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000039 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:32125130
|texte= [Individualized treatment recommendations for lung cancer patients at different stages of treatment during the outbreak of 2019 novel coronavirus disease epidemic].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:32125130" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a CovidV1
| This area was generated with Dilib version V0.6.33. |  |